Showing 3431-3440 of 5689 results for "".
- MacuLogix Launches AMD Academyhttps://modernod.com/news/maculogix-launches-amd-academy/2479861/MacuLogix has launched its AMD Academy, an online learning community for current AdaptDx users, delivering video-based product training and a user forum to facilitate discussion of best practices and answers to user questions. “MacuLogix provides extensive, in-person training to eac
- Report: Takeda May Sell Shire Assets to Reduce Debt Following $62 Billion Purchasehttps://modernod.com/news/report-takeda-may-sell-shire-assets-to-reduce-debt-following-62-billion-purchase/2479892/According to people close to the situation, Takeda is considering selling Shire’s eye care business, including the dry eye disease treatment Xiidra (lifitegrast), once it completes the purchase of the company, Bloomberg
- New Joystick for the Keratograph 5M With Release Functionhttps://modernod.com/news/new-joystick-for-the-keratograph-5m-with-release-function/2479900/The Oculus Keratograph 5M now comes equipped with a new joystick, which includes a release function. The new feature enables the user to capture images and video sequences with the push of a button on the device. No need any more to switch to the mouse – the user’s hand stays resting on the new
- Commentary: Endothelial Cell Density After Iris-Fixated Phakic IOLhttps://modernod.com/news/endothelial-cell-density-after-iris-fixated-phakic-iol/2479908/There are three main types of phakic intraocular lenses (pIOL): those secured in the anterior chamber angle, those secured to the iris, and those placed between the crystalline lens and the iris. The latter two types are approved by the US Food and Drug Administration for use in the United States
- Scientific Data for Novel Adeno-Associated Virus Gene Therapy in Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa Publishedhttps://modernod.com/news/scientific-data-for-novel-adeno-associated-virus-gene-therapy-in-rhodopsin-mediated-autosomal-dominant-retinitis-pigmentosa-published/2479920/Ophthotech announced that scientists at the University of Pennsylvania (Penn) and University of Florida published proof-of-concept study results on an adeno-associated virus (AAV) gene therapy product candidate for the treatment of rhodopsin-mediated autosomal dominant retinitis pigmentosa (RHO-a
- CDC Launches the Nation’s First Vision and Eye Health Surveillance Systemhttps://modernod.com/news/cdc-launches-the-nations-first-vision-and-eye-health-surveillance-system/2479924/The Centers for Disease Control and Prevention (CDC) has developed the nation’s first Vision and Eye Health Surveillance System (VEHSS). Launched in collaboration with the National Opinion Research Center (NORC), the VEHSS is designed to help health care professionals, researchers, policymakers,
- Roche’s Genentech Unit to Cut 223 Jobs in UShttps://modernod.com/news/roches-genentech-unit-to-cut-223-jobs-in-us/2479930/Roche’s Genentech unit plans to cut 223 jobs from its South San Francisco, California headquarters by the end of the year. The company, which disclosed the staff reductions in a Worker Adjustment and Retraining Notification (WARN) posted by the State of California’s Employment Develop
- Regeneron Faces Delay to FDA Approval of 12-Week Dosing Schedule for Eylea in Wet AMDhttps://modernod.com/news/regeneron-faces-delay-to-fda-approval-of-12-week-dosing-schedule-for-eylea-in-wet-amd/2479946/Regeneron announced that the FDA issued a complete response letter regarding a filing seeking approval of a 12-week dosing schedule for »Eylea (aflibercept) in patients wit
- Eyenovia’s EYN PG21 Trial Evaluating High-Precision Microdose of Latanoprost Demonstrates IOP Lowering and Patient Usabilityhttps://modernod.com/news/eyenovias-eyn-pg21-trial-evaluating-high-precision-microdose-of-latanoprost-demonstrates-iop-lowering-and-patient-usability/2479947/Eyenovia announced positive results of its EYN PG21 proof-of-concept study of microdose latanoprost for the lowering of IOP and patient usability. The EYN PG21 clinical study investigated the medication administration effectiveness and IOP lowering effect of
- Gene Mutation Found in Aqueous Humor May Detect Vitreoretinal Lymphomahttps://modernod.com/news/gene-mutation-found-in-aqueous-humor-may-detect-vitreoretinal-lymphoma/2479958/Ultrasensitive droplet digital polymerase chain reaction (ddPCR) is a potential new biopsy tool to diagnose and monitor vitreoretinal lymphoma (VRL), new research from the Netherlands suggests, according to a